agilon health, inc. - Common stock, $0.01 par value (AGL)

CUSIP: 00857U107

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common stock, $0.01 par value
Shares outstanding
16,608,126
Total 13F shares
377,603,391
Share change
-9,129,125
Total reported value
$260,251,806
Put/Call ratio
14%
Price per share
$0.69
Number of holders
197
Value change
-$10,790,545
Number of buys
100
Number of sells
102

Security key

00857U107

Report period

Q4 2025

Institutions

197

Top holders

10

Top shareholders of AGL - agilon health, inc. - Common stock, $0.01 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
MORGAN STANLEY
13D/G 13F
Company
12%
50,200,249
$192,768,956 $0 31 Mar 2025
North Peak Capital Management, LLC
13D/G 13F
Company
9.5%
39,411,957
$40,594,316 +$18,411,536 30 Sep 2025
VANGUARD GROUP INC
13F 13D/G
Company · The Vanguard Group
4.4%
from 13D/G
24,292,603
$25,021,381 30 Sep 2025
FMR LLC
13F 13D/G
Company
3.7%
from 13D/G
15,645,831
$16,115,206 30 Sep 2025
WELLINGTON MANAGEMENT GROUP LLP
13D/G
3.6%
14,986,897
$57,549,684 -$51,420,591 31 Mar 2025
Capital World Investors
13D/G 13F
Company
2.6%
10,852,943
$9,333,531 -$29,857,186 29 Aug 2025
Capital International Investors
13D/G 13F
Company
2.4%
9,892,742
$22,060,815 -$27,739,262 30 Jun 2025
Ronald A. Williams
3/4/5
Director
22%
3,675,257
$10,915,513 28 May 2025
Sharad Mansukani
3/4/5
Director
8.1%
1,352,757
$4,017,688 28 May 2025
John William Wulf
3/4/5
Director
2.2%
365,857
$230,087 +$50,941 12 Nov 2025
Karen McLoughlin
3/4/5
Director
0.91%
151,890
$451,113 28 May 2025
Silvana Battaglia
3/4/5
Director
0.87%
144,868
$430,257 28 May 2025
Diana Mckenzie
3/4/5
Director
0.83%
137,543
$408,502 28 May 2025
Clayton, Dubilier & Rice, LLC
13F
Company
602%
100,000,000
$103,000,000 30 Sep 2025
13F
BlackRock, Inc.
13F
Company
146%
24,197,634
$24,923,563 30 Sep 2025
13F
CenterBook Partners LP
13F
Company
69%
11,428,027
$11,770,868 30 Sep 2025
13F
D. E. Shaw & Co., Inc.
13F
Company
60%
9,993,871
$10,293,687 30 Sep 2025
13F
STATE STREET CORP
13F
Company
46%
7,707,516
$7,938,741 30 Sep 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
43%
7,142,423
$7,357,677 30 Sep 2025
13F
Rock Springs Capital Management LP
13F
Company
42%
6,966,300
$7,175,289 30 Sep 2025
13F
GOLDMAN SACHS GROUP INC
13F
Company
41%
6,771,284
$6,974,422 30 Sep 2025
13F
Rubicon Founders LLC
13F
Company
38%
6,292,396
$6,481,168 30 Sep 2025
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
37%
6,125,568
$6,309,335 30 Sep 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
33%
5,414,614
$5,577,052 30 Sep 2025
13F
CITADEL ADVISORS LLC
13F
Company
23%
3,856,211
$3,971,897 30 Sep 2025
13F
JACOBS LEVY EQUITY MANAGEMENT, INC
13F
Company
19%
3,099,850
$3,192,845 30 Sep 2025
13F
Nuveen, LLC
13F
Company
18%
3,065,008
$3,156,958 30 Sep 2025
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
18%
2,998,838
$3,088,803 30 Sep 2025
13F
Voleon Capital Management LP
13F
Company
17%
2,741,039
$2,823,270 30 Sep 2025
13F
NORTHERN TRUST CORP
13F
Company
16%
2,649,258
$2,728,736 30 Sep 2025
13F
JPMORGAN CHASE & CO
13F
Company
13%
2,105,297
$2,168,456 30 Sep 2025
13F
JANE STREET GROUP, LLC
13F
Company
11%
1,860,037
$1,915,838 30 Sep 2025
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
8.8%
1,459,600
$1,503,388 30 Sep 2025
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
8.3%
1,378,133
$1,419,477 30 Sep 2025
13F
UBS Group AG
13F
Company
5.8%
968,230
$997,276 30 Sep 2025
13F
Bank of New York Mellon Corp
13F
Company
5.1%
851,374
$876,915 30 Sep 2025
13F
TUDOR INVESTMENT CORP ET AL
13F
Company
4.9%
805,756
$829,929 30 Sep 2025
13F
Invesco Ltd.
13F
Company
4.6%
768,315
$791,364 30 Sep 2025
13F
Engineers Gate Manager LP
13F
Company
4.5%
740,498
$762,713 30 Sep 2025
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
4.4%
736,998
$759,108 30 Sep 2025
13F
DEUTSCHE BANK AG\
13F
Company
4.4%
733,882
$755,898 30 Sep 2025
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
4.3%
705,930
$727,108 30 Sep 2025
13F
Swiss National Bank
13F
Company
3.6%
590,800
$608,524 30 Sep 2025
13F
Connor, Clark & Lunn Investment Management Ltd.
13F
Company
3.3%
547,045
$563,456 30 Sep 2025
13F
Susquehanna Portfolio Strategies, LLC
13F
Company
3.2%
535,975
$552,054 30 Sep 2025
13F
XTX Topco Ltd
13F
Company
3%
506,171
$521,356 30 Sep 2025
13F
BARCLAYS PLC
13F
Company
3%
491,135
$505,869 30 Sep 2025
13F
RHUMBLINE ADVISERS
13F
Company
2.8%
461,850
$475,691 30 Sep 2025
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
2.6%
427,996
$442,365 30 Sep 2025
13F
Inspire Investing, LLC
13F
Company
2.6%
427,711
$440,542 30 Sep 2025
13F

Institutional Holders of agilon health, inc. - Common stock, $0.01 par value (AGL) as of Q4 2025

As of 31 Dec 2025, agilon health, inc. - Common stock, $0.01 par value (AGL) was held by 197 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 377,603,391 shares. The largest 10 holders included Clayton, Dubilier & Rice, LLC, MORGAN STANLEY, North Peak Capital Management, LLC, BlackRock, Inc., D. E. Shaw & Co., Inc., GOLDMAN SACHS GROUP INC, VANGUARD GROUP INC, AQR CAPITAL MANAGEMENT LLC, Capital World Investors, and CHARLES SCHWAB INVESTMENT MANAGEMENT INC. This page lists 197 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
188
Q4 2025 holders
197
Holder diff
9
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 Value $ Q4 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .